Nuvation Bio Inc.
NUVB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 171.5% | 56.7% | -46% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 74.5% | 46.7% | 32.1% | 26.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -417.4% | -1,204.8% | -1,714.4% | -860.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -425.2% | -1,220.9% | -1,726.2% | -865.8% |
| EPS Diluted | -0.16 | -0.17 | -0.16 | -0.15 |
| % Growth | 5.9% | -6.3% | -6.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |